Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.610
+0.090 (3.57%)
At close: Mar 9, 2026, 4:00 PM EDT
2.590
-0.020 (-0.77%)
After-hours: Mar 9, 2026, 7:03 PM EDT

Aytu BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Market Capitalization
282017927126
Upgrade
Market Cap Growth
229.57%12.22%97.32%-66.79%-78.89%-26.16%
Upgrade
Enterprise Value
2024161520106
Upgrade
Last Close Price
2.522.182.921.6013.80100.20
Upgrade
PS Ratio
0.450.300.270.120.281.92
Upgrade
PB Ratio
1.901.030.630.230.600.92
Upgrade
EV/Sales Ratio
0.320.360.250.200.211.61
Upgrade
EV/EBITDA Ratio
4.963.022.245.92--
Upgrade
EV/EBIT Ratio
-9.4328.87---
Upgrade
Debt / Equity Ratio
1.561.210.590.470.410.18
Upgrade
Debt / EBITDA Ratio
5.012.681.754.68--
Upgrade
Net Debt / Equity Ratio
-0.56-0.42-0.13-0.11-0.03-0.18
Upgrade
Net Debt / EBITDA Ratio
-1.97-1.01-0.49-1.820.040.86
Upgrade
Net Debt / FCF Ratio
11.353.702.090.880.040.88
Upgrade
Asset Turnover
0.530.550.510.540.480.31
Upgrade
Inventory Turnover
2.101.741.562.233.412.77
Upgrade
Quick Ratio
0.930.990.700.750.640.71
Upgrade
Current Ratio
1.161.261.001.030.930.96
Upgrade
Return on Equity (ROE)
-109.23%-60.76%-37.33%-18.05%-119.62%-50.12%
Upgrade
Return on Assets (ROA)
-0.22%1.31%0.28%-2.37%-11.81%-11.41%
Upgrade
Return on Capital Employed (ROCE)
-0.70%4.20%1.00%-7.70%-52.10%-24.50%
Upgrade
Earnings Yield
-87.59%-69.30%-90.85%-192.92%-408.69%-46.22%
Upgrade
FCF Yield
-2.50%-11.06%-9.85%-58.03%-108.29%-22.45%
Upgrade
Buyback Yield / Dilution
-38.73%-13.40%-65.81%-127.22%-75.54%-270.57%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.